Masayoshi Ajioka

811 total citations
38 papers, 410 citations indexed

About

Masayoshi Ajioka is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masayoshi Ajioka has authored 38 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masayoshi Ajioka's work include Cardiac Arrhythmias and Treatments (12 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Masayoshi Ajioka is often cited by papers focused on Cardiac Arrhythmias and Treatments (12 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Masayoshi Ajioka collaborates with scholars based in Japan, United States and France. Masayoshi Ajioka's co-authors include Takayuki Ozawa, Satoru Sugiyama, Hiroyuki Osanai, Mika Hayakawa, Kazuyoshi Sakai, Hiroshi Asano, Toyoaki Murohara, Takahiro Kambara, Naoki Sato and Masaharu Kato and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Masayoshi Ajioka

34 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayoshi Ajioka Japan 12 230 102 75 64 53 38 410
Caterina Pettinella Italy 7 282 1.2× 111 1.1× 100 1.3× 18 0.3× 88 1.7× 7 528
Csaba András Dézsi Hungary 13 290 1.3× 62 0.6× 53 0.7× 38 0.6× 32 0.6× 38 487
Anna Komosa Poland 14 256 1.1× 54 0.5× 48 0.6× 99 1.5× 43 0.8× 43 465
Christopher N. Floyd United Kingdom 13 329 1.4× 51 0.5× 30 0.4× 36 0.6× 91 1.7× 30 505
T. W. B. Gehr United States 12 135 0.6× 28 0.3× 161 2.1× 61 1.0× 30 0.6× 20 585
Kurt Reinhart United States 14 229 1.0× 94 0.9× 70 0.9× 48 0.8× 19 0.4× 27 642
Kelvin Kuan Huei Ng Canada 7 63 0.3× 78 0.8× 162 2.2× 47 0.7× 20 0.4× 10 363
Henry Yu United States 6 259 1.1× 111 1.1× 54 0.7× 38 0.6× 11 0.2× 8 478
Lidija Memon Serbia 12 124 0.5× 53 0.5× 85 1.1× 36 0.6× 8 0.2× 31 491
F. Pamparana Italy 12 228 1.0× 101 1.0× 46 0.6× 69 1.1× 89 1.7× 30 580

Countries citing papers authored by Masayoshi Ajioka

Since Specialization
Citations

This map shows the geographic impact of Masayoshi Ajioka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayoshi Ajioka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayoshi Ajioka more than expected).

Fields of papers citing papers by Masayoshi Ajioka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayoshi Ajioka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayoshi Ajioka. The network helps show where Masayoshi Ajioka may publish in the future.

Co-authorship network of co-authors of Masayoshi Ajioka

This figure shows the co-authorship network connecting the top 25 collaborators of Masayoshi Ajioka. A scholar is included among the top collaborators of Masayoshi Ajioka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayoshi Ajioka. Masayoshi Ajioka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osanai, Hiroyuki, Yuki Tanaka, Takashi Watanabe, et al.. (2024). Distribution of anti‐factor Xa activity in patients with nonvalvular atrial fibrillation receiving 15 mg dose of edoxaban. Journal of Arrhythmia. 40(5). 1126–1130.
2.
Kambara, Takahiro, Rei Shibata, Hiroyuki Osanai, et al.. (2024). Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia. BMC Research Notes. 17(1). 60–60. 3 indexed citations
3.
Sakamoto, Yusuke, et al.. (2023). Efficacy and safety of atrial fibrillation ablation in heart failure patients with left ventricular ejection fraction less than 50%. Indian Pacing and Electrophysiology Journal. 23(5). 135–141.
4.
Yamaguchi, Satoshi, Michio Shimabukuro, Atsushi Tanaka, et al.. (2022). Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial. Diabetes Obesity and Metabolism. 25(2). 354–364. 1 indexed citations
5.
Osanai, Hiroyuki, et al.. (2021). Isolated bilateral external iliac artery dissections with emotional stress. SHILAP Revista de lepidopterología. 9(3). 1312–1314. 2 indexed citations
6.
Sakamoto, Yusuke, et al.. (2021). A case of accessory pathway mapped with ultra‐high‐resolution mapping led to a coronary sinus diverticulum. SHILAP Revista de lepidopterología. 9(3). 1315–1320. 1 indexed citations
7.
Sakamoto, Yusuke, et al.. (2021). Contrast-enhanced computed tomography for optimizing the outcomes of pulmonary vein isolation with cryoablation -the role of isolation of PVs including carina-. Journal of Interventional Cardiac Electrophysiology. 64(2). 455–461. 1 indexed citations
8.
Osanai, Hiroyuki, et al.. (2020). Secondary Cardiac Lymphoma Presenting as Sick Sinus Syndrome and Atrial Fibrillation Which Required Leadless Pacemaker Implantation. Internal Medicine. 60(3). 431–434. 7 indexed citations
9.
Tobe, Akihiro, Hiroyuki Osanai, Akihito Tanaka, et al.. (2020). Comparison of Anti-factor Xa Activity Among Three Different Factor Xa Inhibitors in Non-valvular Atrial Fibrillation Patients with Renal Impairment. Clinical Drug Investigation. 40(6). 567–573. 7 indexed citations
10.
Kambara, Takahiro, Rei Shibata, Hiroyuki Osanai, et al.. (2019). Importance of sodium-glucose cotransporter 2 inhibitor use in diabetic patients with acute heart failure. Therapeutic Advances in Cardiovascular Disease. 13. 335292397–335292397. 15 indexed citations
11.
Tanaka, Atsushi, Hisako Yoshida, Mamoru Nanasato, et al.. (2018). Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study. International Journal of Cardiology. 271. 331–335. 8 indexed citations
12.
Kambara, Takahiro, Rei Shibata, Yosuke Inoue, et al.. (2018). P272Additional use of SGLT2 inhibitors in the treatment of acute decompensated heart failure may prevent acute kidney injury. European Heart Journal. 39(suppl_1). 1 indexed citations
13.
Kuwayama, Tasuku, Hiroyuki Osanai, Masayoshi Ajioka, et al.. (2017). Influence of proton pump inhibitors on blood dabigatran concentrations in Japanese patients with non‐valvular atrial fibrillation. Journal of Arrhythmia. 33(6). 619–623. 21 indexed citations
14.
Sato, Naoki, Wataru Takahashi, Atsushi Hirayama, et al.. (2015). LATE BREAKING CLINICAL TRIAL (JCS 2015) : Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure. Circulation. 79(6). 1237–1247. 10 indexed citations
15.
Nakano, Yoshihisa, Takahisa Kondo, Hiroyuki Osanai, et al.. (2014). Clinical usefulness of measuring prothrombin time and soluble fibrin levels in Japanese patients with atrial fibrillation receiving rivaroxaban. Journal of Cardiology. 65(3). 185–190. 17 indexed citations
16.
Ishikawa, Kiyotake, Katsuhiro Kato, Akihito Tanaka, et al.. (2013). Treatment of Sirolimus-Eluting Stent Restenosis: Additional Stent, Balloon Angioplasty, and Coronary Artery Bypass Graft. Journal of Cardiac Surgery. 28(2). 97–101.
17.
Asano, Hiroshi, Kazuyoshi Sakai, Masayoshi Ajioka, et al.. (2004). PJ-240 The "Rentrop 2" Collateral Flow Will Salvage the Myocardium in Acute Myocardial Infarction?(Acute Myocardial Infarction, Clinical (Diagnosis/Treatment) 8 (IHD) : PJ40)(Poster Session (Japanese)). Japanese Circulation Journal-english Edition. 68. 538. 1 indexed citations
18.
Asakura, Takanori, et al.. (1989). [Report of surgical treatment of ASD in the aged].. PubMed. 42(2). 124–8. 1 indexed citations
19.
Ajioka, Masayoshi, et al.. (1986). The role of phospholipase in the genesis of reperfusion arrhythmia. Journal of Electrocardiology. 19(2). 165–172. 10 indexed citations
20.
Sugiyama, S, et al.. (1985). The effects of dilazep on reperfusion arrhythmias.. PubMed. 35(12). 1802–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Pettinella Breakdown of academic impact, for papers by Csaba András Dézsi Breakdown of academic impact, for papers by Anna Komosa Breakdown of academic impact, for papers by Christopher N. Floyd Breakdown of academic impact, for papers by T. W. B. Gehr Breakdown of academic impact, for papers by Kurt Reinhart Breakdown of academic impact, for papers by Kelvin Kuan Huei Ng Breakdown of academic impact, for papers by Henry Yu Breakdown of academic impact, for papers by Lidija Memon Breakdown of academic impact, for papers by F. Pamparana
Rankless by CCL
2026